Sulzer Medica raises hip numbers again:
This article was originally published in Clinica
Executive Summary
Sulzer Medica, which is facing a costly recall of one of its hip implants, said last week that the number of patients requiring revision surgery has risen to 1,850. According to Reuters, one analyst estimates that the recall will eventually cost around SFr1 billion ($559 million).